A highly selective and sensitive LC-MS/HRMS assay for quantifying coproporphyrins as organic anion-transporting peptide biomarkers.

about

A highly selective and sensitive LC-MS/HRMS assay for quantifying coproporphyrins as organic anion-transporting peptide biomarkers.

Item

http://www.wikidata.org/entity/Q49602657

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A highly selective and sensiti ...... ansporting peptide biomarkers.

@en

A highly selective and sensiti ...... ansporting peptide biomarkers.

@nl

type

Item

label

A highly selective and sensiti ...... ansporting peptide biomarkers.

@en

A highly selective and sensiti ...... ansporting peptide biomarkers.

@nl

prefLabel

A highly selective and sensiti ...... ansporting peptide biomarkers.

@en

A highly selective and sensiti ...... ansporting peptide biomarkers.

@nl

P1476

A highly selective and sensiti ...... ansporting peptide biomarkers.

@en

P2093

A David Rodrigues

http://www.w3.org/2001/XMLSchema#string

Amanda J King-Ahmad

http://www.w3.org/2001/XMLSchema#string

Christopher L Holliman

http://www.w3.org/2001/XMLSchema#string

Ragu Ramanathan

http://www.w3.org/2001/XMLSchema#string

P2860

A validated liquid chromatography-tandem mass spectrometry method for the quantitative determination of 4β-hydroxycholesterol in human plasma.

Integrated quantitative and qualitative workflow for in vivo bioanalytical support in drug discovery using hybrid Q-TOF-MS.

Performance characteristics of a new hybrid quadrupole time-of-flight tandem mass spectrometer (TripleTOF 5600).

Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidance.

Comparison of high-resolution and tandem mass spectrometry for the analysis of nerve agent metabolites in urine.

Principles and applications of LC-MS in new drug discovery.

Urinary porphyrins and heme biosynthetic enzyme activities measured by HPLC in arsenic toxicity.

Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs.

Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: a medicinal chemistry perspective.

Parallelism experiments to evaluate matrix effects, selectivity and sensitivity in ligand-binding assay method development: pros and cons.

P304

1787-1806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/BIO-2017-0181

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28978230

http://www.w3.org/2001/XMLSchema#string